What's new

Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive

Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive

Mar 12, 2025 - 17:05
 0
Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive
Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Adeno-associated viral vector serotype rh10 containing the h...

Next Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Related Posts

Quetiapine

Quetiapine

Mar 11, 2025  0

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Orphan designation: hydroxocobalamin acetate Treatment of homocystinuria and/or methylmalonic acidaemia due to genetic defects of intracellular cobalamin processing, 26/02/2025 Positive

Orphan designation: hydroxocobalamin acetate Treatment ...

Mar 11, 2025  0